Glenmede Trust’s LifePoint Health, Inc. LPNT Stock Holding History

Glenmede Trust’s Portfolio LPNT Stock Details LPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-56	Closed	-$3K	–	2939
2017 Q3	$3K	Buy	+56	New	+$3.33K	﹤0.01%	2536

Other funds holding LPNT

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

LBA

Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Glenmede Trust's LPNT Position: Q4 2017 in Review

Glenmede Trust sold out of LifePoint Health, Inc. (LPNT) in Q4 2017, closing a stake of 56 shares — an estimated $3K sold.

Glenmede Trust first reported a position in LPNT in Q3 2017 and held it in 1 quarter. The position peaked at $3K in Q3 2017. 212 funds tracked by Wall St. Rank hold LPNT as of Q4 2017.

Glenmede Trust reported no remaining LifePoint Health, Inc. position as of Q4 2017 after selling out during the quarter.
Glenmede Trust sold 56 LifePoint Health, Inc. shares in Q4 2017, an estimated $3K.
Glenmede Trust first reported a position in LifePoint Health, Inc. in Q3 2017 and held it in 1 quarter.
Glenmede Trust's LifePoint Health, Inc. position peaked at $3K in Q3 2017.
212 funds tracked by Wall St. Rank held LifePoint Health, Inc. as of Q4 2017.

Based on Glenmede Trust's 13F filing for Q4 2017, filed 15 Feb 2018.